Index/Organizations/Journal of Clinical Oncology

Journal of Clinical Oncology

Journal

Fact-Checks

5 results

Jan 17, 2026

What randomized clinical trials of ivermectin in cancer are currently registered and what are their designs and endpoints?

Only a single actively registered randomized or early-phase trial of ivermectin in human cancer patients is clearly documented in the available reporting: a phase I/II study combining oral ivermectin ...

Nov 27, 2025

Which cancer types (e.g., colorectal, glioblastoma) are being studied with ivermectin in trials in 2024–2025?

Clinical research testing ivermectin in cancer patients in 2024–2025 is sparse and concentrated mainly on triple‑negative breast cancer (TNBC) immunotherapy combinations; multiple reviews and preclini...

Jan 12, 2026

What published results exist from NCT05318469 (ivermectin + balstilimab) regarding safety and pharmacokinetics?

Published results for NCT05318469 are limited to conference abstracts and trial summaries that report tolerability and early activity signals: an ASCO/Journal of Clinical Oncology abstract states the ...

Dec 12, 2025

What PSA threshold after prostatectomy indicates need for salvage radiation?

Guidelines and large studies do not set a single PSA “trigger” after radical prostatectomy; contemporary recommendations commonly consider salvage radiation once PSA is detectable and rising, with thr...

Nov 15, 2025

How do PSA thresholds and kinetics guide timing decisions for salvage radiotherapy?

Guidance and studies converge on one principle: earlier salvage radiotherapy (SRT) after radical prostatectomy—when PSA is low—is associated with better biochemical control, metastasis‑free outcomes a...